Palladium-109 labeled anti-melanoma monoclonal antibodies

USH819H · kind H · statutory invention registration

Assignee

• The United States of America, as Represented by the Secretary of Energy · US

Inventors

• Suresh C. Srivastava · Port Jefferson, US
• Rashid A. Fawwaz · Pelham, US
• Soldano Ferrone · Buffalo, US

Key dates

• Grant date: Sep 4, 1990

Classification

• Technology area (CPC —): General

Abstract

Palladium-109, a beta-emitting radionuclide, when chelated to anti-melanoma monoclonal antibody demonstrates high uptake in melanoma and thus is useful for tumor therapy.